Why ACRS? Aclaris Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
ACRS
$4.75+0.01 (+0.11%)
Market OpenUpdated 11:54 AM EDT
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.